Abbott Laboratories - Other Cashflows From Financing Activities

Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Cashflows-From-Financing-Activities" stands at 0.334 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2023.

Abbott Laboratories's third quarter result of 0.069 Billion USD for the item "Other Cashflows From Financing Activities" represents an increase of 246.81 percent compared to it's second quarter result.

Also, Abbott Laboratories's third quarter result of 0.069 Billion USD for the item "Other Cashflows From Financing Activities" represents a decrease of -25.00 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Abbott Laboratories's third quarter result of 0.334 Billion USD for the item "Other Cashflows From Financing Activities" represents a decrease of -6.44 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -5.55 Billion United States Dollars compared to the value the year prior.
The 1 year change is -5.55 Billion United States Dollars.
The 3 year change is 0.126 Billion United States Dollars.
The 5 year change is 0.109 Billion United States Dollars.
The 10 year change is -0.068 Billion United States Dollars.

The Serie's long term average value is 0.357 Billion United States Dollars. It's latest available value, on 09/30/2025, is -0.023 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is +6.33 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -6.35 Billion.